Clinical Trials Logo

Filter by:
NCT ID: NCT03809572 Terminated - Clinical trials for Postpartum Depression

Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy

Start date: March 22, 2019
Phase: N/A
Study type: Interventional

The study is a pilot randomized control trial of a validated intervention, Mindfulness Based Cognitive Therapy (MBCT) adapted for pregnancy, developed to reduce risk for postpartum depression. This study examines emotion regulation as a potential mechanism of action, at both the behavioral and neurobiological level, that carries forward to the postpartum period. A secondary mechanism of action to be explored is cognitive control. This study will also consider other potential influences on treatment response and psychiatric outcomes, including perinatal stress and depressive symptoms. The study population is pregnant women age 21-45.

NCT ID: NCT03809481 Terminated - Clinical trials for Heparin-induced Thrombocytopenia

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

HITSOVA
Start date: May 16, 2019
Phase: Phase 3
Study type: Interventional

An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Treatment of Subjects with Acute HIT (HITSOVA study)

NCT ID: NCT03809234 Terminated - Neuropathic Pain Clinical Trials

Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers

Start date: May 20, 2019
Phase: Phase 1
Study type: Interventional

To determine the time-course of plasma and CSF concentrations of intravenous (IV) ondansetron in healthy subjects, with and without selective inhibition of Pgp efflux transporter.

NCT ID: NCT03809130 Terminated - Malignant Neoplasm Clinical Trials

Effectiveness of an Online Intervention Targeting Cancer-related Fatigue

Start date: December 10, 2018
Phase: N/A
Study type: Interventional

This trial studies how well Untire application intervention works in reducing cancer-related fatigue in cancer patients and survivors.The Untire application focuses on themes that have been identified as causing or contributing to cancer-related fatigue. It may provide information and tips to improve lifestyle, give exercises for body and mind to increase energy levels, offer weekly reports to measure progress, and offer access to an online support community.

NCT ID: NCT03809117 Terminated - Infectious Diarrhea Clinical Trials

Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea

Start date: November 19, 2018
Phase: N/A
Study type: Interventional

This research study will test a laboratory test called Film-Array Gastrointestinal (GI) Panel. This GI Panel is a test that can identify the bacteria or viruses that may cause diarrhea. This test will enable the ED doctor to better understand the cause of diarrhea to try to determine the best treatment. The primary objective of this study is to determine if testing ED patients who complain of diarrhea will lead to more optimal use of antibiotics. Optimal use of antibiotics is defined as the most appropriate antibiotic to treat a specified pathogen.

NCT ID: NCT03808961 Terminated - Parkinson's Disease Clinical Trials

Niacin for Parkinsons Disease

NAPS
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

(1) To examine the blood, urine and spinal fluid of persons with Parkinson's to look for evidence of inflammation and; (2) whether 18 months of vitamin B3(niacin or niacinamide) supplementation may reduce the inflammation and/or improve PD motor and non-motor symptoms.

NCT ID: NCT03808714 Terminated - Smoking Cessation Clinical Trials

Smoking Cessation Tailored to Rural Young Adult African American Men:

Start date: April 26, 2016
Phase: N/A
Study type: Interventional

Our preliminary data shows that 39.9% of AA men between 19 and 30 years of age who resided in rural Alabama smoke cigarettes. Although it has been well established that a combination of pharmacotherapy and advice-oriented counseling and/or cognitive behavioral interventions are efficacious in promoting smoking cessation across diverse populations, these evidence-based treatments for tobacco dependence have not proven to be effective/efficacious (or even accessible) among some subpopulations suffering disproportionally from tobacco-related morbidity and mortality. The overall goal of this feasibility study is to make adaptations to these evidence-based approaches, and develop, implement, and examine the feasibility and scalability of a theory-based, culturally relevant smoking cessation intervention for young adult AA men in rural Alabama who smoke cigarettes. Our formative assessments point to a cognitive-behavioral intervention delivered by a trained Community Health Worker with the support from an "expert" physician who can deliver the pharmacological component via Skype through an integrated approach. The proposed study will address the next three steps in this process: development of the intervention, pretesting, and feasibility. First, we will develop the intervention with input from a Community Advisory Committee, followed by an iterative process by which the target audience will be exposed to materials and messages to provide feedback (pretesting). Once all intervention components are finalized, we will recruit participants, randomly assign them to intervention/control groups, pilot test, and evaluate the intervention. The comparison group will be the Alabama Tobacco Quitline with 8 weeks of Nicotine Replacement Therapy to be consistent with the pharmacological approach proposed for the intervention. The primary outcome will be 7-day point prevalence abstinence (defined as no cigarettes in the past 7 days and verified through measurement of exhaled carbon monoxide levels) at 6-month follow-up. We will also conduct detailed treatment fidelity and scalability assessments (acceptability, feasibility, potential reach and adoption, alignment with the strategic context) to inform a full-scale efficacy trial.

NCT ID: NCT03808545 Terminated - Multiple Sclerosis Clinical Trials

Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS

ABC's of MS
Start date: February 26, 2019
Phase: N/A
Study type: Interventional

Multiple sclerosis (MS) is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the U.S. Cardiometabolic risk factors including obesity and hyperlipidemia are common among people with MS, and these risk factors are associated with severity and frequency of MS relapses and disease progression. People with MS often experience symptoms of pain, fatigue, and depression, which make adhering to a healthy lifestyle difficult, as evidenced by the high rates of unhealthy behaviors including poor diet and physical inactivity among this group. Physical activity has reduced symptoms of MS and improved metabolic risk profiles, but little research has focused on the role of a dietary intervention combined with physical activity in this group. Therefore, the purpose of this study is to test the efficacy of a combined diet and physical activity intervention for reducing cardiometabolic risks and MS symptoms when compared to a physical activity intervention alone.

NCT ID: NCT03807856 Terminated - Acute Pancreatitis Clinical Trials

Treating Acute Pancreatitis With Dabigatran, a Pilot Study

Start date: June 24, 2019
Phase: Phase 1
Study type: Interventional

Researchers are studying the safety and efficacy of Dabigatran in the treatment of acute pancreatitis.

NCT ID: NCT03807349 Terminated - Clinical trials for Garden Grade II Subcapital Fracture of Femoral Neck

N-Force Screws Augmented With N-Force Blue in Hip Fractures

N-Force
Start date: February 21, 2019
Phase: N/A
Study type: Interventional

The objective of this prospective study is to confirm safety and performance of N-Force Screws augmented with N-Force Blue applied in intracapsular proximal femur fracture treatment.